Cargando…

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia as a hemostatic agent for centuries. ABS contains a standardized combination of the plants namely Glycyrrhiza glabra,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciftciler, Rafiye, Ciftciler, Ali Erdinc, Malkan, Umit Yavuz, Haznedaroglu, Ibrahim C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026817/ https://www.ncbi.nlm.nih.gov/pubmed/32110403 http://dx.doi.org/10.1177/2050312120907811

Ejemplares similares

Ankaferd hemostat: from molecules to medicine
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2020)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)

Endothelial Cells, Ankaferd Hemostat, and Estradiol
por: Ardıçoğlu, Yasemin, et al.
Publicado: (2016)

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
por: Koluman, Ahmet, et al.
Publicado: (2016)

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
por: Simsek, Cem, et al.
Publicado: (2017)

A New Candidate as a Hemostatic Agent for Difficult Situations During Variceal Bleeding: Ankaferd Blood Stopper
por: Ozaslan, Ersan, et al.
Publicado: (2011)

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat
por: HAZNEDAROĞLU, İbrahim Celalettin, et al.
Publicado: (2020)

Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate
por: Dinçol, Muzaffer Emir, et al.
Publicado: (2016)

Experimental Investigation of the Effects of a Blood Stopper Agent (Ankaferd Blood Stopper) on Bone Surfaces
por: Şimşek, Hasan Onur, et al.
Publicado: (2013)

Effect of ankaferd blood stopper in experimental peritoneal adhesion model
por: Karaca, Gokhan, et al.
Publicado: (2016)

Successful Application of Ankaferd Blood Stopper in a Patient with Lower Gastrointestinal Bleeding
por: Beyazit, Yavuz, et al.
Publicado: (2011)

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine
por: Okay, Mufide, et al.
Publicado: (2019)

Assessment of the efficacy of Ankaferd blood stopper on the prevention of postoperative pericardial adhesions
por: Nazli, Yunus, et al.
Publicado: (2014)

Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury
por: DURHAN, Abdullah, et al.
Publicado: (2020)

The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice
por: KOŞMAZ, Koray, et al.
Publicado: (2021)

Drug interaction potential of Ankaferd blood stopper(®) in human hepatocarcinoma cells
por: SEMİZ, Aslı
Publicado: (2022)

Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury
por: Ergin, Metin, et al.
Publicado: (2021)

Analysing the blood-stemming effect of Ankaferd Blood Stopper in medulla spinalis surgery
por: TÜRKÖZ, Dursun, et al.
Publicado: (2020)

Anti-inflammatory Efficiency of Ankaferd Blood Stopper in Experimental Distal Colitis Model
por: Koçak, Erdem, et al.
Publicado: (2013)

Effects of Ankaferd BloodStopper on bone healing in an ovariectomized osteoporotic rat model
por: Ezirganli, Şeref, et al.
Publicado: (2017)

The efficacy of Ankaferd Blood Stopper(®) in an experimental Asherman syndrome model created in rats
por: Büyük, Başak, et al.
Publicado: (2019)

Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study
por: Kılıçgün, Ali, et al.
Publicado: (2011)

Success Rates of Ankaferd Blood Stopper and Ferric Sulfate as Pulpotomy Agents in Primary Molars
por: Cantekin, Kenan, et al.
Publicado: (2014)

Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) on early bone healing
por: İŞLER, Sabri Cemil, et al.
Publicado: (2010)

Histopathological and mechanical effects of Ankaferd Blood Stopper® on wound healing in rats: an experimental model
por: HANCIOĞLU, Sertaç, et al.
Publicado: (2020)

The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
por: Karabıyık, Afife, et al.
Publicado: (2012)

In Vitro Efficacy of the Ankaferd Galenic Hemostatic Extract as a Germicidal Agent
por: METİN, Bayram, et al.
Publicado: (2016)

Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, ankaferd blood stopper, on vascular tissue in a rat aortic bleeding model
por: Kandemir, Ozer, et al.
Publicado: (2010)

The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial
por: Kazancıoğlu, Hakkı Oğuz, et al.
Publicado: (2013)

Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases
por: Koluman, Ahmet, et al.
Publicado: (2017)

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System
por: Akbal, Erdem, et al.
Publicado: (2013)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach
por: Koçak, Engin, et al.
Publicado: (2019)

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content
por: Beyazit, Fatma, et al.
Publicado: (2020)

Effectiveness of Ankaferd BloodStopper in Prophylaxis and Treatment of Oral Mucositis in Childhood Cancers Evaluated with Plasma Citrulline Levels
por: Patıroğlu, Türkan, et al.
Publicado: (2018)

The potential effects of Ankaferd blood stopper and fibrin sealent on sleeve gastrectomy staple-line healing: An experimental study
por: Sakar, Alkan, et al.
Publicado: (2019)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfo45vj4tn4v6ovbvv7a47ethi